Basic information Safety Supplier Related

Temozolomideacid

Basic information Safety Supplier Related

Temozolomideacid Basic information

Product Name:
Temozolomideacid
Synonyms:
  • 3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetrazinecarboxylic acid
  • Temozolomide-8-carboxylic acid
  • 3,4-Dihydro-3-Methyl-4-oxo-iMidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic Acid
  • teMozoloMide acid 97%
  • 3-Methyl-4-oxo-3,4-dihydroiMidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid
  • Temozolomideacid
  • Temozolomide Impurity 1
  • Temozolomide Impurity C
CAS:
113942-30-6
MF:
C6H5N5O3
MW:
195.14
Product Categories:
  • Bases & Related Reagents
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Nucleotides
  • Pharmaceuticals
Mol File:
113942-30-6.mol
More
Less

Temozolomideacid Chemical Properties

Melting point:
166-168°C
Boiling point:
487.7±37.0 °C(Predicted)
Density 
1.97±0.1 g/cm3(Predicted)
storage temp. 
Inert atmosphere,2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
2.88±0.20(Predicted)
form 
Solid
color 
White to Off-White
Stability:
Hygroscopic
More
Less

Safety Information

HS Code 
2933.99.9000
More
Less

Temozolomideacid Usage And Synthesis

Chemical Properties

White Solid

Uses

A metabolite of Temozolomide (T017775) as antitumor agent.

Synthesis

85622-93-1

113942-30-6

General procedure: Example 1 Preparation of 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid (EP0252682) 1. 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide (2.577 mmol, 0.5 g) was mixed with concentrated sulfuric acid (4 mL) under stirring conditions. 2. a solution was prepared by dissolving sodium nitrite (9.4 mmol, 0.65 g) in 2.6 mL of water. 3. Slowly add the aqueous sodium nitrite solution dropwise to the above mixture under cooling in an ice bath (keeping the temperature below 15°C). 4. After the dropwise addition, the reaction mixture was stirred at room temperature overnight. 5. 10 g of ice was added to the reaction mixture and cooling was continued in an ice bath for 1 hour. 6. The solid product was collected by filtration. 7. The collected solid product was dried under vacuum to give 0.493 g of 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid. The yield was 98.6%.

References

[1] European Journal of Medicinal Chemistry, 2002, vol. 37, # 4, p. 323 - 332
[2] Patent: EP1798234, 2007, A1. Location in patent: Page/Page column 11
[3] Patent: US2018/79754, 2018, A1. Location in patent: Paragraph 0082; 0101-0102
[4] European Journal of Medicinal Chemistry, 2017, vol. 127, p. 691 - 702
[5] Journal of Medicinal Chemistry, 2002, vol. 45, # 25, p. 5458 - 5470

TemozolomideacidSupplier

Olix (Shanghai) Pharmaceutical Technology Co., Ltd Gold
Tel
17316404525 17316404525
Email
209533805@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
ChemShuttle, Inc.
Tel
0510-83588313-811 18800520310
Email
sales@chemshuttle.com